
LINK . SPRINGER . COM {
}
Title:
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram | Cancer Immunology, Immunotherapy
Description:
Background Chimeric antigen receptor (CAR) T cells for refractory or relapsed (r/r) B cell no-Hodgkin lymphoma (NHL) patients have shown promising clinical effectiveness. However, the factors impacting the clinical response of CAR-T therapy have not been fully elucidated. We here investigate the independent influencing factors of the efficacy of CD19 CAR-T cell infusion in the treatment of r/r B-NHL and to establish an early prediction model. Methods A total of 43 r/r B-NHL patients were enrolled in this retrospective study. The patients’ general data were recorded, and the primary endpoint is the patients’ treatment response. The independent factors of complete remission (CR) and partial remission (PR) were investigated by univariate and binary logistic regression analysis, and the prediction model of the probability of CR was constructed according to the determined independent factors. Receiver operating characteristic (ROC) and calibration plot were used to assess the discrimination and calibration of the established model. Furthermore, we collected 15 participators to validate the model. Results Univariate analysis and binary logistic regression analysis of 43 patients showed that the ratio of central memory T cell (Tcm) and naïve T cell (Tn) in cytotoxic T cells (Tc) was an independent risk factor for response to CD19 CAR-T cell therapy in r/r B-NHL. On this basis, the area under the curve (AUC) of Tcm in the Tc and Tn in the Tc nomogram model was 0.914 (95%CI 0.832–0.996), the sensitivity was 83%, and the specificity was 74.2%, which had excellent predictive value. We did not found the difference of the progression-free survival (PFS). Conclusions The ratio of Tcm and Tn in Tc was found to be able to predict the treatment response of CD19 CAR-T cells in r/r B-NHL. We have established a nomogram model for the assessment of the CD19 CAR-T therapy response presented high specificity and sensitivity.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Insurance
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure how the site profits.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
cart, cells, patients, cell, treatment, response, therapy, model, article, pubmed, clinical, lymphoma, tcm, central, factors, google, scholar, proportion, blood, baseline, infusion, study, analysis, prediction, efficacy, curve, cas, early, results, predictive, tumor, fig, nomogram, car, remission, found, cohort, table, data, zhang, showed, auc, tianjin, bnhl, supplementary, cancer, univariate, logistic, roc, independent,
Topics {✒️}
pcdh-mscv-mcs-ef1-t2a-puro vector anti-human cd45ro pe-vio770 hosmer–lemeshow chi-squared test anti-human cd8 percp-cy7 anti-human cd127 pe article download pdf anti-human cd62l apc anti-human cd25 apc cd28-coated magnetic beads anti-human cd3 percp chimeric antigen receptor car t-cell therapy cd3-coated magnetic beads anti-human cd4 fitc univariate mann–whitney test cell-mediated immune response long-term clinical outcomes large b-cell lymphoma observed short-term efficacy binary logistic regression refractory/relapsed b-cell relapsed/refractory b-cell central memory subset hosmer–lemeshow test small sample size b-cell malignancies cuicui lyu privacy choices/manage cookies receiver operating characteristic long-term outcomes long-term safety full access long-term survival mann–whitney test binary analysis showed central memory cd8 + drive clinical relapse central memory cells fdg uptake decreased fdg uptake increased central clinical college univariate analysis showed single-cell profiling great predictive power b-nhl patients based imaging results showed mingfeng zhao refractory b-cell clinical trial data bone marrow blasts
Schema {🗺️}
WebPage:
mainEntity:
headline:A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram
description:Chimeric antigen receptor (CAR) T cells for refractory or relapsed (r/r) B cell no-Hodgkin lymphoma (NHL) patients have shown promising clinical effectiveness. However, the factors impacting the clinical response of CAR-T therapy have not been fully elucidated. We here investigate the independent influencing factors of the efficacy of CD19 CAR-T cell infusion in the treatment of r/r B-NHL and to establish an early prediction model. A total of 43 r/r B-NHL patients were enrolled in this retrospective study. The patients’ general data were recorded, and the primary endpoint is the patients’ treatment response. The independent factors of complete remission (CR) and partial remission (PR) were investigated by univariate and binary logistic regression analysis, and the prediction model of the probability of CR was constructed according to the determined independent factors. Receiver operating characteristic (ROC) and calibration plot were used to assess the discrimination and calibration of the established model. Furthermore, we collected 15 participators to validate the model. Univariate analysis and binary logistic regression analysis of 43 patients showed that the ratio of central memory T cell (Tcm) and naïve T cell (Tn) in cytotoxic T cells (Tc) was an independent risk factor for response to CD19 CAR-T cell therapy in r/r B-NHL. On this basis, the area under the curve (AUC) of Tcm in the Tc and Tn in the Tc nomogram model was 0.914 (95%CI 0.832–0.996), the sensitivity was 83%, and the specificity was 74.2%, which had excellent predictive value. We did not found the difference of the progression-free survival (PFS). The ratio of Tcm and Tn in Tc was found to be able to predict the treatment response of CD19 CAR-T cells in r/r B-NHL. We have established a nomogram model for the assessment of the CD19 CAR-T therapy response presented high specificity and sensitivity.
datePublished:2024-01-27T00:00:00Z
dateModified:2024-01-27T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-023-03618-w
keywords:
Refractory/relapsed B cell non-Hodgkin’s lymphoma
Chimeric antigen receptor T cells
Predictive models
Treatment response
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig5_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
volumeNumber:73
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Xiaomei Zhang
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Rui Sun
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Meng Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yifan Zhao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xinping Cao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Ruiting Guo
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yi Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xingzhong Liu
affiliation:
name:Nankai University
address:
name:State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Cuicui Lyu
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Mingfeng Zhao
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram
description:Chimeric antigen receptor (CAR) T cells for refractory or relapsed (r/r) B cell no-Hodgkin lymphoma (NHL) patients have shown promising clinical effectiveness. However, the factors impacting the clinical response of CAR-T therapy have not been fully elucidated. We here investigate the independent influencing factors of the efficacy of CD19 CAR-T cell infusion in the treatment of r/r B-NHL and to establish an early prediction model. A total of 43 r/r B-NHL patients were enrolled in this retrospective study. The patients’ general data were recorded, and the primary endpoint is the patients’ treatment response. The independent factors of complete remission (CR) and partial remission (PR) were investigated by univariate and binary logistic regression analysis, and the prediction model of the probability of CR was constructed according to the determined independent factors. Receiver operating characteristic (ROC) and calibration plot were used to assess the discrimination and calibration of the established model. Furthermore, we collected 15 participators to validate the model. Univariate analysis and binary logistic regression analysis of 43 patients showed that the ratio of central memory T cell (Tcm) and naïve T cell (Tn) in cytotoxic T cells (Tc) was an independent risk factor for response to CD19 CAR-T cell therapy in r/r B-NHL. On this basis, the area under the curve (AUC) of Tcm in the Tc and Tn in the Tc nomogram model was 0.914 (95%CI 0.832–0.996), the sensitivity was 83%, and the specificity was 74.2%, which had excellent predictive value. We did not found the difference of the progression-free survival (PFS). The ratio of Tcm and Tn in Tc was found to be able to predict the treatment response of CD19 CAR-T cells in r/r B-NHL. We have established a nomogram model for the assessment of the CD19 CAR-T therapy response presented high specificity and sensitivity.
datePublished:2024-01-27T00:00:00Z
dateModified:2024-01-27T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00262-023-03618-w
keywords:
Refractory/relapsed B cell non-Hodgkin’s lymphoma
Chimeric antigen receptor T cells
Predictive models
Treatment response
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_Fig5_HTML.png
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
volumeNumber:73
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Xiaomei Zhang
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Rui Sun
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Meng Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yifan Zhao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xinping Cao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Ruiting Guo
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yi Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xingzhong Liu
affiliation:
name:Nankai University
address:
name:State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Cuicui Lyu
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Mingfeng Zhao
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
volumeNumber:73
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
name:Nankai University
address:
name:State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China
type:PostalAddress
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Xiaomei Zhang
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
name:Rui Sun
affiliation:
name:Nankai University
address:
name:School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
name:Meng Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
name:Yifan Zhao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
name:Xinping Cao
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
name:Ruiting Guo
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
name:Yi Zhang
affiliation:
name:Tianjin Medical University
address:
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
type:PostalAddress
type:Organization
name:Xingzhong Liu
affiliation:
name:Nankai University
address:
name:State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
name:Cuicui Lyu
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
name:Mingfeng Zhao
affiliation:
name:Nankai University
address:
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:School of Medicine, Nankai University, Tianjin, China
name:School of Medicine, Nankai University, Tianjin, China
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
name:First Central Clinical College, Tianjin Medical University, Tianjin, China
name:State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Molecular Microbiology and Technology of the Ministry of Education, Department of Microbiology, College of Life Sciences, Nankai University, Tianjin, China
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
name:Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
External Links {🔗}(131)
- What's the monthly income of https://www.springernature.com/gp/authors?
- What's the monthly income of https://link.springernature.com/home/?
- What's the total monthly financial gain of https://order.springer.com/public/cart?
- Check the income stats for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://submission.nature.com/new-submission/262/3 's total income per month
- How much profit is https://beta.springernature.com/pre-submission?journalId=262 making per month?
- How much money does https://doi.org/10.6004%2Fjnccn.2017.7045 make?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29118234 making per month?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20CAR%20T%20cells%20in%20non-hodgkin%E2%80%99s%20lymphoma&journal=J%20Natl%20Compr%20Cancer%20Netw%20JNCCN&doi=10.6004%2Fjnccn.2017.7045&volume=15&issue=11&pages=1429-1437&publication_year=2017&author=Avanzi%2CMP&author=Brentjens%2CRJ is on a monthly basis
- Earnings of https://doi.org/10.1056%2FNEJMoa1804980
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30501490
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Tisagenlecleucel%20in%20adult%20relapsed%20or%20refractory%20diffuse%20large%20B-cell%20lymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1804980&volume=380&issue=1&pages=45-56&publication_year=2019&author=Schuster%2CSJ&author=Bishop%2CMR&author=Tam%2CCS&author=Waller%2CEK&author=Borchmann%2CP&author=McGuirk%2CJP
- How much profit does https://doi.org/10.1016%2FS1470-2045%2818%2930864-7 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30518502's financial summary
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Long-term%20safety%20and%20activity%20of%20axicabtagene%20ciloleucel%20in%20refractory%20large%20B-cell%20lymphoma%20%28ZUMA-1%29%3A%20a%20single-arm%2C%20multicentre%2C%20phase%201%E2%80%932%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930864-7&volume=20&issue=1&pages=31-42&publication_year=2019&author=Locke%2CFL&author=Ghobadi%2CA&author=Jacobson%2CCA&author=Miklos%2CDB&author=Lekakis%2CLJ&author=Oluwole%2COO?
- How profitable is https://doi.org/10.1016%2FS1470-2045%2821%2900375-2?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34516954 produce monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Long-term%20clinical%20outcomes%20of%20tisagenlecleucel%20in%20patients%20with%20relapsed%20or%20refractory%20aggressive%20B-cell%20lymphomas%20%28JULIET%29%3A%20a%20multicentre%2C%20open-label%2C%20single-arm%2C%20phase%202%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2821%2900375-2&volume=22&issue=10&pages=1403-1415&publication_year=2021&author=Schuster%2CSJ&author=Tam%2CCS&author=Borchmann%2CP&author=Worel%2CN&author=McGuirk%2CJP&author=Holte%2CH?
- Earnings of https://doi.org/10.1158%2F1078-0432.CCR-19-0101
- How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20efficacy%20and%20tumor%20microenvironment%20influence%20in%20a%20dose-escalation%20study%20of%20anti-CD19%20chimeric%20antigen%20receptor%20T%20cells%20in%20refractory%20B-cell%20non-hodgkin%E2%80%99s%20lymphoma&journal=Clin%20Cancer%20Res%20Off%20J%20Am%20Assoc%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-19-0101&volume=25&issue=23&pages=6995-7003&publication_year=2019&author=Yan%2CZX&author=Li%2CL&author=Wang%2CW&author=OuYang%2CBS&author=Cheng%2CS&author=Wang%2CL rake in every month?
- Get to know https://doi.org/10.7150%2Fthno.54546's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33754022 pull in monthly?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978305 is on a monthly basis
- How much profit is http://scholar.google.com/scholar_lookup?&title=Peripheral%20eosinophil%20counts%20predict%20efficacy%20of%20anti-CD19%20CAR-T%20cell%20therapy%20against%20B-lineage%20non-Hodgkin%20lymphoma&journal=Theranostics&doi=10.7150%2Fthno.54546&volume=11&issue=10&pages=4699-4709&publication_year=2021&author=Jia%2CQ&author=Qin%2CD&author=He%2CF&author=Xie%2CQ&author=Ying%2CZ&author=Zhang%2CY making per month?
- Profit of https://doi.org/10.1158%2F2159-8290.CD-21-1586
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35554512 generate monthly?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357057 have?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Sequential%20single%20cell%20transcriptional%20and%20protein%20marker%20profiling%20reveals%20TIGIT%20as%20a%20marker%20of%20CD19%20CAR-T%20cell%20dysfunction%20in%20patients%20with%20non-Hodgkin%E2%80%99s%20lymphoma&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-21-1586&volume=12&pages=1886-2190&publication_year=2022&author=Jackson%2CZ&author=Hong%2CC&author=Schauner%2CR&author=Dropulic%2CB&author=Caimi%2CPF&author=Lima%2CM?
- What is the monthly revenue of https://doi.org/10.1182%2Fbloodadvances.2020003001?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33180899 make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686887?
- How much does http://scholar.google.com/scholar_lookup?&title=Predictive%20factors%20of%20early%20progression%20after%20CAR%20T-cell%20therapy%20in%20relapsed%2Frefractory%20diffuse%20large%20B-cell%20lymphoma&journal=Blood%20Adv&doi=10.1182%2Fbloodadvances.2020003001&volume=4&issue=22&pages=5607-5615&publication_year=2020&author=Vercellino%2CL&author=Blasi%2CR&author=Kanoun%2CS&author=Tessoulin%2CB&author=Rossi%2CC&author=D%E2%80%99Aveni-Piney%2CM pull in monthly?
- What's the profit of https://doi.org/10.3389%2Ffimmu.2022.858590?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35371098?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970344?
- See how much http://scholar.google.com/scholar_lookup?&title=Identification%20of%20the%20predictive%20models%20for%20the%20treatment%20response%20of%20refractory%2Frelapsed%20B-cell%20all%20patients%20receiving%20CAR-T%20therapy&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2022.858590&volume=13&publication_year=2022&author=Gu%2CJ&author=Liu%2CS&author=Cui%2CW&author=Dai%2CH&author=Cui%2CQ&author=Yin%2CJ makes per month
- How much money does https://doi.org/10.1182%2Fbloodadvances.2020001900 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32702097 generate monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391155
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=High%20metabolic%20tumor%20volume%20is%20associated%20with%20decreased%20efficacy%20of%20axicabtagene%20ciloleucel%20in%20large%20B-cell%20lymphoma&journal=Blood%20Adv&doi=10.1182%2Fbloodadvances.2020001900&volume=4&issue=14&pages=3268-3276&publication_year=2020&author=Dean%2CEA&author=Mhaskar%2CRS&author=Lu%2CH&author=Mousa%2CMS&author=Krivenko%2CGS&author=Lazaryan%2CA?
- What's the monthly income of https://doi.org/10.1200%2FJCO.21.02143?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Impact%20of%20TP53%20genomic%20alterations%20in%20large%20B-cell%20lymphoma%20treated%20with%20CD19-chimeric%20antigen%20receptor%20T-cell%20therapy&journal=J%20Clin%20Oncol%20Off%20J%20Am%20Soc%20Clin%20Oncol&doi=10.1200%2FJCO.21.02143&volume=40&issue=4&pages=369-381&publication_year=2022&author=Shouval%2CR&author=Alarcon%20Tomas%2CA&author=Fein%2CJA&author=Flynn%2CJR&author=Markovits%2CE&author=Mayer%2CS generate?
- https://doi.org/10.1158%2F2159-8290.CD-20-0037's financial summary
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32238396 make?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Not%20so%20FASt%3A%20tumor%20cells%20resisting%20death%20drive%20CAR%20T-cell%20dysfunction&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-0037&volume=10&issue=4&pages=492-494&publication_year=2020&author=Green%2CMR&author=Neelapu%2CSS?
- How much profit does https://doi.org/10.3390%2Fcancers8030036 make?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26999211 have monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810120?
- Get to know http://scholar.google.com/scholar_lookup?&title=Different%20subsets%20of%20T%20cells%20memory%20effector%20functions%20and%20CAR-T%20immunotherapy&journal=Cancers&doi=10.3390%2Fcancers8030036&volume=8&issue=3&publication_year=2016&author=Golubovskaya%2CV&author=Wu%2CL's earnings
- How much profit does https://doi.org/10.3389%2Ffonc.2019.00767 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31482064 income
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709654 make?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Anti-CD19%20chimeric%20antigen%20receptor%20T%20Cells%20in%20combination%20with%20nivolumab%20are%20safe%20and%20effective%20against%20relapsed%2Frefractory%20B-cell%20non-hodgkin%20lymphoma&journal=Front%20Oncol&doi=10.3389%2Ffonc.2019.00767&volume=9&publication_year=2019&author=Cao%2CY&author=Lu%2CW&author=Sun%2CR&author=Jin%2CX&author=Cheng%2CL&author=He%2CX
- Check the income stats for https://doi.org/10.1038%2Fs41392-022-00915-1
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35370290 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977349 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20NOXA%20as%20a%20pivotal%20regulator%20of%20resistance%20to%20CAR%20T-cell%20therapy%20in%20B-cell%20malignancies&journal=Signal%20Transduct%20Target%20Ther&doi=10.1038%2Fs41392-022-00915-1&volume=7&issue=1&publication_year=2022&author=Yan%2CX&author=Chen%2CD&author=Wang%2CY&author=Guo%2CY&author=Tong%2CC&author=Wei%2CJ net monthly?
- How much does https://doi.org/10.3390%2Fcancers13174279 rake in every month?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34503088 earns monthly
- Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428364
- How much money does http://scholar.google.com/scholar_lookup?&title=Clinical%20and%20product%20features%20associated%20with%20outcome%20of%20DLBCL%20patients%20to%20CD19-targeted%20CAR%20T-Cell%20therapy&journal=Cancers&doi=10.3390%2Fcancers13174279&volume=13&issue=17&publication_year=2021&author=Lamure%2CS&author=Laethem%2CF&author=Verbizier%2CD&author=Lozano%2CC&author=Gehlkopf%2CE&author=Tudesq%2CJJ make?
- What's https://doi.org/10.1182%2Fbloodadvances.2020002394's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33035333 make?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556133's total income per month
- http://scholar.google.com/scholar_lookup?&title=Tumor%20burden%2C%20inflammation%2C%20and%20product%20attributes%20determine%20outcomes%20of%20axicabtagene%20ciloleucel%20in%20large%20B-cell%20lymphoma&journal=Blood%20Adv&doi=10.1182%2Fbloodadvances.2020002394&volume=4&issue=19&pages=4898-4911&publication_year=2020&author=Locke%2CFL&author=Rossi%2CJM&author=Neelapu%2CSS&author=Jacobson%2CCA&author=Miklos%2CDB&author=Ghobadi%2CA income
- What's the monthly income of https://doi.org/10.1038%2Fs41591-020-1061-7?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33020644's gross income?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446909 pull in?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Characteristics%20of%20anti-CD19%20CAR%20T%20cell%20infusion%20products%20associated%20with%20efficacy%20and%20toxicity%20in%20patients%20with%20large%20B%20cell%20lymphomas&journal=Nat%20Med&doi=10.1038%2Fs41591-020-1061-7&volume=26&issue=12&pages=1878-1887&publication_year=2020&author=Deng%2CQ&author=Han%2CG&author=Puebla-Osorio%2CN&author=Ma%2CMCJ&author=Strati%2CP&author=Chasen%2CB?
- Earnings of https://doi.org/10.1016%2Fj.ccell.2022.09.013
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36240777's earnings
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Depletion%20of%20BATF%20in%20CAR-T%20cells%20enhances%20antitumor%20activity%20by%20inducing%20resistance%20against%20exhaustion%20and%20formation%20of%20central%20memory%20cells&journal=Cancer%20Cell&doi=10.1016%2Fj.ccell.2022.09.013&volume=40&issue=11&pages=1407-22.e7&publication_year=2022&author=Zhang%2CX&author=Zhang%2CC&author=Qiao%2CM&author=Cheng%2CC&author=Tang%2CN&author=Lu%2CS
- How much does https://doi.org/10.1038%2Fs41573-019-0051-2 net monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31900462
- How much profit does http://scholar.google.com/scholar_lookup?&title=%E2%80%98Off-the-shelf%E2%80%99%20allogeneic%20CAR%20T%20cells%3A%20development%20and%20challenges&journal=Nat%20Rev%20Drug%20Discov&doi=10.1038%2Fs41573-019-0051-2&volume=19&issue=3&pages=185-199&publication_year=2020&author=Depil%2CS&author=Duchateau%2CP&author=Grupp%2CSA&author=Mufti%2CG&author=Poirot%2CL generate?
- How much revenue does https://doi.org/10.1038%2Fs41591-018-0010-1 generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29713085 generate?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117613?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Determinants%20of%20response%20and%20resistance%20to%20CD19%20chimeric%20antigen%20receptor%20%28CAR%29%20T%20cell%20therapy%20of%20chronic%20lymphocytic%20leukemia&journal=Nat%20Med&doi=10.1038%2Fs41591-018-0010-1&volume=24&issue=5&pages=563-571&publication_year=2018&author=Fraietta%2CJA&author=Lacey%2CSF&author=Orlando%2CEJ&author=Pruteanu-Malinici%2CI&author=Gohil%2CM&author=Lundh%2CS?
- What's https://doi.org/10.1172%2FJCI85309's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27111235 make?
- See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887159 makes per month
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=CD19%20CAR-T%20cells%20of%20defined%20CD4%2B%3ACD8%2B%20composition%20in%20adult%20B%20cell%20ALL%20patients&journal=J%20Clin%20Investig&doi=10.1172%2FJCI85309&volume=126&issue=6&pages=2123-2138&publication_year=2016&author=Turtle%2CCJ&author=Hanafi%2CLA&author=Berger%2CC&author=Gooley%2CTA&author=Cherian%2CS&author=Hudecek%2CM
- Learn about the earnings of https://doi.org/10.1158%2F2159-8290.CD-20-1677
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33820778?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419030's financial summary
- How much profit does http://scholar.google.com/scholar_lookup?&title=Integrative%20bulk%20and%20single-cell%20profiling%20of%20premanufacture%20T-cell%20populations%20reveals%20factors%20mediating%20long-term%20persistence%20of%20CAR%20T-cell%20therapy&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-1677&volume=11&issue=9&pages=2186-2199&publication_year=2021&author=Chen%2CGM&author=Chen%2CC&author=Das%2CRK&author=Gao%2CP&author=Chen%2CCH&author=Bandyopadhyay%2CS generate?
- How profitable is https://citation-needed.springer.com/v2/references/10.1007/s00262-023-03618-w?format=refman&flavour=references?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaomei%20Zhang bring in each month?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaomei%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rui%20Sun?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rui%20Sun%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Meng%20Zhang
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Meng%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yifan%20Zhao's financial summary
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yifan%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xinping%20Cao's gross income?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xinping%20Cao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ruiting%20Guo rake in every month?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ruiting%20Guo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yi%20Zhang?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yi%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xingzhong%20Liu?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xingzhong%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cuicui%20Lyu makes per month
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cuicui%20Lyu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mingfeng%20Zhao
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mingfeng%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Explore the financials of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_MOESM1_ESM.tif
- What's the financial outcome of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_MOESM2_ESM.tif?
- Find out how much https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_MOESM3_ESM.docx earns monthly
- How much does https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-023-03618-w/MediaObjects/262_2023_3618_MOESM4_ESM.docx earn?
- http://creativecommons.org/licenses/by/4.0/'s total income per month
- What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=A%20CAR-T%20response%20prediction%20model%20for%20r%2Fr%20B-NHL%20patients%20based%20on%20a%20T%20cell%20subset%20nomogram&author=Xiaomei%20Zhang%20et%20al&contentID=10.1007%2Fs00262-023-03618-w©right=The%20Author%28s%29&publication=1432-0851&publicationDate=2024-01-27&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-023-03618-w gross monthly?
- What's the income of https://citation-needed.springer.com/v2/references/10.1007/s00262-023-03618-w?format=refman&flavour=citation?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
- What's the financial intake of https://www.springernature.com/gp/products?
- How much does https://www.springernature.com/gp/librarians net monthly?
- How much income does https://www.springernature.com/gp/societies have?
- How much does https://www.springernature.com/gp/partners bring in each month?
- What's the financial intake of https://www.springer.com/?
- Explore the financials of https://www.nature.com/
- How much profit does https://www.biomedcentral.com/ make?
- What's the financial intake of https://www.palgrave.com/?
- What's the financial gain of https://www.apress.com/?
- How much cash flow does https://www.springernature.com/gp/legal/ccpa have monthly?
- How much money does https://www.springernature.com/gp/info/accessibility generate?
- What's the financial outcome of https://support.springernature.com/en/support/home?
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
- What are the total earnings of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref